Clinical Trial: Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07655453) titled 'Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005' on June 10.

Brief Summary: This study is a single-center, single-arm, open-label, investigator-initiated early exploratory clinical trial designed to evaluate the safety and efficacy of STR-P005 in subjects with relapsed/refractory autoimmune diseases.

The study will employ the traditional "3+3" dose escalation model, setting up 3 dose groups: Amg/kg, Bmg/kg, C mg/kg. Dose Group 1 will serve as the starting dose, with two cohorts A and B within this group aimed at optimizing the dosing frequency of STR-P005. Cohort A will receive dosing ev...